Who invested in Cytogel Pharma

3 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Follow Cytogel Pharma and see its new rounds in your feed. Start following

Funding summaryUpdated 5 Nov 2026

$5.1Mraised across 3 rounds since 2010, from 3 sources

$2.2MVenture$240KDebt$2.7MVenture

Latest round: Venture, $2.7MJan 2015
Step-upi: 11.2×
Investors: 0

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20112012201320142015

$2.2MVenture$240KDebt$2.7MVenture

First round: Venture, $2.2M
Biggest round: $2.7M
Usual gap between rounds: 3.8 years

The rounds

Jan 2015
Venture$2.7M
No investor was named in the report.
From a historical funding recordSEC filing: $2.7M sold, first sale Jan 2015
Mar 2014
Debt$240K
No investor was named in the report.
From a historical funding recordSEC filing: $240K sold, first sale Mar 2014
May 2010
Venture$2.2M
No investor was named in the report.
Reported by sec.govSEC filing: $2.2M sold, first sale May 2010

Founders and team

From Cytogel Pharma's own website: 2 on the team.

Dean MaglarisCEO & Chair of Board of Managers
Mary R. DriverDirector, Clinical Development Operations

Also claim to have backed them

This firm lists Cytogel Pharma as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.